Loading clinical trials...
Loading clinical trials...
Effect of Endovascular Thrombectomy for Femoral Popliteal Vein Thrombosis on Venous Valve Function Maintenance: a Single-center, Single-arm Prospective Observational Study
To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.
All patients presenting with symptoms in the lower extremity due to the femoral venous thrombosis involving or not involving iliac and popliteal veins treated with percutaneously pharmacomechanical catheter-directed thrombolysis via AngioJet devices or anticoagulation alone were included in this study.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Chuzhou People's Hospital
Chuzhou, Anhui, China
Center hospital of Putu
Shanghai, Shanghai Municipality, China
Central Hospital of Songjiang
Shanghai, Shanghai Municipality, China
North Branch of Shanghai Ninth People's Hospital
Shanghai, Shanghai Municipality, China
Shanghai Ninth People's Hospital
Shanghai, Shanghai Municipality, China
Fengchen Hospital
Shanghai, Shanghai Municipality, China
Taizhou Municipal hospital
Taizhou, Zhejiang, China
Start Date
June 6, 2022
Primary Completion Date
June 6, 2025
Completion Date
June 6, 2025
Last Updated
May 14, 2025
100
ESTIMATED participants
AngioJet device
DEVICE
anticoagulation alone
OTHER
Lead Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions